+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Fusion Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Fusion Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Insulin Like Growth Factor (IGF) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Insulin Like Growth Factor (IGF) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A1 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A1 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
5-HT2C Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2C Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
D2 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

D2 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Bradykinin Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Bradykinin Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Kallikrein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Kallikrein Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M2 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Sickle Cell Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Sickle Cell Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Encephalomyelitis - Pipeline Insight, 2025 - Product Thumbnail Image

Encephalomyelitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2025 - Product Thumbnail Image

Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Borderline Personality Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Borderline Personality Disorders - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Influenza - Pipeline Insight, 2025 - Product Thumbnail Image

Influenza - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Hypertension - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Homocystinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Homocystinuria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Severe Acne Vulgaris - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Acne Vulgaris - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more